Sr. Scientist - Product Development at Alamar Biosciences

Fremont, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life SciencesIndustries

Requirements

Ph.D. in Biochemistry, Molecular Biology, or related field with 5+ years of industry experience; or M.S. with 8+ years of relevant experience
Hands-on experience with reagent development, assay optimization, and product transfer in a regulated and/or ISO-compliant environment
Significant experience with NPI, having performed product transfer on multiple commercially launched products
Deep understanding of protein and nucleic acid assay technologies (e.g., ELISA, qPCR, NGS, immunoassays, and proximity ligation or extension assays)
Experience with DOE, statistical analysis, and process validation using JMP or similar statistical software
Familiarity with quality systems, including ISO9001, ISO13485, and design control processes
Strong organizational, communication, and documentation skills with exceptional attention to detail
Ability to thrive in a fast-paced, collaborative, and mission-driven environment
Significant experience with automated liquid handling systems and high-throughput assays and/or manufacturing processes
Preferred Qualifications
Data analysis capabilities using languages such as R or Python
Knowledge of regulatory requirements for IVD and RUO products

Responsibilities

Lead cross-functional efforts to develop and optimize reagents, assay components, and kit configurations for Alamar’s NULISA platform
Drive product transfer from R&D to manufacturing, including the development of robust, scalable, and cost-effective production processes
Design and execute experiments to characterize product performance, stability, and manufacturability
Develop and validate QC methods and specifications to ensure product consistency and compliance with quality standards
Author and review technical documentation including SOPs, batch records, product specifications, and technology transfer packages
Collaborate with R&D, Manufacturing, and Quality teams to support design transfer, risk assessments, and process validations
Mentor junior scientists, providing technical guidance and project leadership
Lead continuous improvement initiatives and root cause investigations for product or process deviations

Skills

Assay Development

Reagent Optimization

Product Transfer

QC Methods

NPI Leadership

Proteomics

Manufacturing Scale-up

Experiment Design

Stability Testing

SOP Authoring

Technology Transfer

Kit Configuration

Alamar Biosciences

Develops technology for protein detection and measurement

About Alamar Biosciences

Alamar Biosciences focuses on the study of proteins, known as proteomics, to enhance disease detection and treatment. The company has created NULISA™, a technology that can detect and measure proteins in the human body with high sensitivity and a wide range. This allows researchers and clinicians to profile clinically relevant protein biomarkers, which are essential for developing new diagnostic tests and treatments for various diseases. Alamar's ARGO™ system complements NULISA™ by providing a fully automated, high-throughput platform for precision proteomics. Unlike competitors, Alamar's technology simplifies the process, reducing the need for extensive technical expertise, making it more accessible to clients. The goal of Alamar Biosciences is to improve our understanding of proteins in health and disease, ultimately leading to better early detection and treatment options.

Hayward, CaliforniaHeadquarters

2018Year Founded

$225.7MTotal Funding

GRANTCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

401(k) Company Match

401(k) Retirement Plan

Performance Bonus

Company Equity

Risks

Increased competition from Olink and SomaLogic may impact Alamar's market share.

Scaling production in Europe and APAC could strain resources and affect quality.

Regulatory hurdles in new regions may delay product launches and affect revenue.

Differentiation

Alamar's NULISA™ technology offers unprecedented sensitivity in protein detection.

The ARGO™ system automates high-throughput proteomics, reducing the need for technical expertise.

Alamar's focus on early disease detection sets it apart in the biotechnology field.

Upsides

ISO 13485:2016 certification boosts Alamar's credibility in the medical device industry.

European expansion with Milan headquarters enhances market reach and client service.

$10M investment accelerates Alzheimer's diagnostics development, strengthening Alamar's market position.

Land your dream remote job 3x faster with AI

Try Jobo Free